Patents by Inventor John Marken

John Marken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human B7 polypeptide B7-H3A
    Publication number: 20060154313
    Abstract: This invention relates to B7-H3A, a new member of the human B7 polypeptide family, methods of making such polypeptides, and to methods of using them to treat immunological conditions and to identify compounds that alter B7-H3A polypeptide activities.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 13, 2006
    Applicant: Immunex Corporation
    Inventors: Dirk Anderson, John Marken
  • Human cDNAs encoding polypeptides having kinase functions
    Publication number: 20050233355
    Abstract: The invention is directed to purified and isolated human polypeptides having kinase function, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, the use of such polypeptides and fragmented peptides in phosphorylation reactions and as molecular weight markers, the use of such polypeptides and fragmented peptides as controls for peptide fragmentation, the use of such polypeptides in screening assays, and kits comprising these reagents.
    Type: Application
    Filed: January 31, 2005
    Publication date: October 20, 2005
    Inventors: G. Virca, Timothy Bird, Dirk Anderson, John Marken
  • Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use
    Patent number: 5597707
    Abstract: The present invention definitively identifies and characterizes the tumor-associated antigen immunologically recognized by the murine monoclonal antibody L6. Further, the present invention provides the nucleotide sequence which encodes the L6 antigen. Various diagnostic, prophylactic and therapeutic methods comprising the L6 antigen and the nucleotide sequence which encodes the L6 antigen are also provided.
    Type: Grant
    Filed: April 15, 1993
    Date of Patent: January 28, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: John Marken, Gary L. Schieven, Ingegerd Hellstrom, Karl E. Hellstrom, Alejandro Aruffo